Elevation of m6A level by overexpression of the m6A writer METTL3 can cause cardiac hypertrophy [32], while m6A eraser FTO attenuates cardiac dysfunction in mice with pressure overload-induced heart failure via N6-demethylation [72]. Here, METTL3 is linked to cardiac hypertrophy.